CYP1B1 expression in ovarian cancer in the laying hen Gallus domesticus

Gynecologic Oncology

Volumn 112, Issue 1, 2009, Pages 171-178

  Zhuge, Yan ^a   Lagman, Jo Ann J ^a   Ansenberger, Kristine ^a   Mahon, Cassandra J ^a   Daikoku, Takiko ^b   Dey, Sudhansu K ^b   Bahr, Janice M ^c   Hales, Dale B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Chicken model; Cytochrome P450; Estrogen metabolism; Ovarian epithelial cancer; Ovarian surface epithelium; Postovulatory follicle

Indexed keywords

CYTOCHROME P450 1B1; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; ENZYME LOCALIZATION; EVALUATION; FEMALE; FROZEN SECTION; GENE EXPRESSION; GRANULOSA CELL; HEN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; OVARY CANCER; OVARY FOLLICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TISSUE FIXATION;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; OVARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 57649103091     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.09.026     Document Type: Article

References (35)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Auersperg N., Wong A.S., Choi K.C., Kang S.K., and Leung P.C. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22 (2001) 255-288
3. Vanderhyden B.C., Shaw T.J., and Ethier J.F. Animal models of ovarian cancer. Reprod Biol Endocrinol 1 (2003) 67
4. Kim J.H., Stansbury K.H., Walker N.J., Trush M.A., Strickland P.T., and Sutter T.R. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19 (1998) 1847-1853
5. Tsuchiya Y., Nakajima M., and Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 227 (2005) 115-124
6. Stoilov I., Akarsu A.N., and Sarfarazi M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 6 (1997) 641-647
7. Tsuchiya Y., Nakajima M., Kyo S., Kanaya T., Inoue M., and Yokoi T. Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res 64 (2004) 3119-3125
8. Cavalieri E., Chakravarti D., Guttenplan J., Hart E., Ingle J., Jankowiak R., et al. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 1766 (2006) 63-78
9. Hayes C.L., Spink D.C., Spink B.C., Cao J.Q., Walker N.J., and Sutter T.R. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci U S A 93 (1996) 9776-9781
10. Zhu B.T., and Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19 (1998) 1-27
11. Murray G.I., Taylor M.C., McFadyen M.C., McKay J.A., Greenlee W.F., Burke M.D., et al. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57 (1997) 3026-3031
12. McFadyen M.C., Breeman S., Payne S., Stirk C., Miller I.D., Melvin W.T., et al. Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1. J Histochem Cytochem 47 (1999) 1457-1464
13. McFadyen M.C., Cruickshank M.E., Miller I.D., McLeod H.L., Melvin W.T., Haites N.E., et al. Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer. Br. J. Cancer 85 (2001) 242-246
14. Downie D., McFadyen M.C., Rooney P.H., Cruickshank M.E., Parkin D.E., Miller I.D., et al. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res 11 (2005) 7369-7375
15. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A 94 (1997) 10937-10942
16. Murray G.I., Melvin W.T., Greenlee W.F., and Burke M.D. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu Rev Pharmacol Toxicol 41 (2001) 297-316
17. McKay J.A., Melvin W.T., Ah-See A.K., Ewen S.W., Greenlee W.F., Marcus C.B., et al. Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Lett 374 (1995) 270-272
18. Fathalla M.F. Incessant ovulation-a factor in ovarian neoplasia?. Lancet 2 (1971) 163
19. Landen Jr. C.N., Birrer M.J., and Sood A.K. Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 26 (2008) 995-1005
20. Fredrickson T.N. Ovarian tumors of the hen. Environ Health Perspect 73 (1987) 35-51
21. Bancroft J., and Stevens A. Theory and practice of histological techniques. 3rd ed (1990), Churchill Livingstone, Edinburgh London Melbourne and New York P726
22. Vidal J.D., Vandevoort C.A., Marcus C.B., Lazarewicz N.R., and Conley A.J. 2,3,7,8-tetrachlorodibenzo-p-dioxin induces CYP1B1 expression in human luteinized granulosa cells. Arch Biochem Biophys 439 (2005) 53-60
23. Toprak A.B., Vatansever S., and Ozbilgin K. Computer assisted image analysis of peroxidase stained endometrial tissue. Turk J med Sci (2006) 285-290
24. Lim H., Gupta R.A., Ma W.G., Paria B.C., Moller D.E., Morrow J.D., et al. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev 13 (1999) 1561-1574
25. Muskhelishvili L., Thompson P.A., Kusewitt D.F., Wang C., and Kadlubar F.F. In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues. The Journal Of Histochemistry And Cytochemistry: Off J Histochem Soc 49 (2001) 229-236
26. Lee K.A., and Bahr J.M. Utilization of substrates for testosterone and estradiol-17 beta production by small follicles of the chicken ovary. Domest Anim Endocrinol 11 (1994) 307-314
27. Murdoch W.J., Van Kirk E.A., and Alexander B.M. DNA damages in ovarian surface epithelial cells of ovulatory hens. Exp Biol Med (Maywood) 230 (2005) 429-433
28. Murdoch W.J., Townsend R.S., and McDonnel A.C. Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/survival and apoptosis. Biol Reprod 65 (2001) 1417-1424
29. Bahr J.M., and Johnson P.A. Reproduction in poultry. 4th ed (1991), Academic Press, New York 555-575
30. Rothchild I., and Fraps R.M. On the function of ruptured ovarian follicle of the domestic fowl. Proceedings of the society for experimental biology and medicine (1944), Society for Experimental Biology and Medicine, New York 79-82
31. Rodriguez-Burford C., Barnes M.N., Berry W., Partridge E.E., and Grizzle W.E. Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 81 (2001) 373-379
32. Urick M.E., and Johnson P.A. Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecol Oncol 103 (2006) 673-678
33. Hales D.B., Zhuge Y., Lagman J.A.J., Ansenberger K., Mahon C., Narua A., et al. Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus). Endocrine (2008) in press
34. Stammer K., Edassery S.L., Barua A., Bitterman P., Bahr J.M., Hales D.B., et al. Selenium-binding protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol 109 (2008) 115-121
35. Barua A., Bradaric M., Edassary S., Rotmensch J., Bitterman P., Hales D., et al. Anti-tumor antibodies and ovarian cancer in women and hens. In: Special American Association for Cancer Research conference, molecular diagnostics in cancer theraperutic development: maximizing opportunities for individualized treatment. Chicago, IL: Scholar-in-Training Award; 2006.